- ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.
The drug would be the first such treatment in Europe.
Mylan execs have criticized the FDA, which they say has been too slow to approve competitors to complex drugs.
Gold nears two-month high as investors take "safety first" approach
FTSE 100 could see ex-dividend impact at the opening bell.